Potency correction - EAUnion opinion [Regulatives / Guidelines]

posted by mittyri – Russia, 2018-06-24 00:53 (2274 d 21:48 ago) – Posting: # 18953
Views: 6,061

Hi ElMaestro,

I don't have any experience of using that workaround and I bet noone has in Russia.
BTW I compared 'the gold standard' EMA Guideline and EAUnion Guideline.
(note that sections 4.1.2 and relevant in EAUnion GL are pretty similar)
EMA:
4.1.8 In bioequivalence studies, the pharmacokinetic parameters should in general not be adjusted for differences in assayed content of the test and reference batch. However, in exceptional cases where a reference batch with an assay content differing less than 5% from test product cannot be found (see section 4.1.2) content correction could be accepted.

EAUnion:
72 In bioequivalence studies, the pharmacokinetic parameters should in general not be adjusted for differences in assayed content of the test and reference batch. However, in exceptional cases where a reference batch with an assay content differs less than 5% from test product (in accordance with subsection 2 of current section) content correction could be accepted.
:confused::-D
Why bother? Just close that backdoor :cool:

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,225 posts in 4,879 threads, 1,652 registered users;
41 visitors (0 registered, 41 guests [including 8 identified bots]).
Forum time: 22:41 CEST (Europe/Vienna)

We absolutely must leave room for doubt
or there is no progress and no learning.
There is no learning without having to pose a question.
And a question requires doubt.
People search for certainty.
But there is no certainty.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5